Authors:
KOHLER G
KOSCHINSKY T
HAASTERT B
MOSER W
DIEDRICH T
MULLER G
ENGELBRECHT R
GRIES FA
Citation: G. Kohler et al., DIADOQ - AN ELECTRONIC MEDICAL RECORD SYSTEM - EVALUATION BY DIABETESSPECIALISTS IN PRACTICES, Diabetologia, 41, 1998, pp. 983-983
Authors:
DU XL
SUI GZ
BUNTING C
KOSCHINSKY T
ROSEN P
Citation: Xl. Du et al., ACTIVATION OF HUMAN ENDOTHELIAL-CELLS AND FIBROBLASTS IS REGULATED BYDIFFERENT MECHANISMS, Diabetologia, 41, 1998, pp. 1221-1221
Citation: Xl. Du et al., DIFFERENT MECHANISMS ARE RESPONSIBLE FOR ACTIVATION OF NF-KAPPA-B IN HUMAN FIBROBLASTS AND ENDOTHELIAL-CELLS, Diabetes, 47, 1998, pp. 436-436
Citation: Hm. Heise et al., EX-VIVO DETERMINATION OF BLOOD-GLUCOSE BY MICRODIALYSIS IN COMBINATION WITH INFRARED ATTENUATED TOTAL-REFLECTION SPECTROSCOPY, Fresenius' journal of analytical chemistry, 359(1), 1997, pp. 83-87
Authors:
BRUULSEMA JT
HAYWARD JE
FARRELL TJ
PATTERSON MS
HEINEMANN L
BERGER M
KOSCHINSKY T
SANDAHLCHRISTIANSEN J
ORSKOV H
Citation: Jt. Bruulsema et al., CORRELATION BETWEEN BLOOD-GLUCOSE CONCENTRATION IN DIABETICS AND NONINVASIVELY MEASURED TISSUE OPTICAL-SCATTERING COEFFICIENT, Optics letters, 22(3), 1997, pp. 190-192
Authors:
VIBERTI G
SLAMA G
POZZA G
CZYZYK A
BILOUS RW
GRIES A
KEEN H
FULLER JH
MENZINGER G
DIMARIO U
NAVALESI R
BRUNETTI P
PIRAS G
MUGGEO M
TIENGO A
FEDERLE D
DEFERRARI D
NOACCO C
CHARBONNEL B
SELAM J
VAGUE P
DROUIN P
HALIMI S
GRESZCZAK W
CZEKALSKI S
SIERADZKI J
FOVENYI J
KERENYI Z
KAMMERER L
SAUDEK F
VONDRA K
ANDEL M
DRORAKOVA L
HEPP KD
KOSCHINSKY T
LEHNERT H
STANDL E
MARSHALL S
BOULTON A
MACCUISH A
HYER S
Citation: G. Viberti et al., EARLY CLOSURE OF EUROPEAN PIMAGEDINE TRIAL, Lancet, 350(9072), 1997, pp. 214-215
Authors:
KOSCHINSKY T
HE CJ
MITSUHASHI T
BUCALA R
LIU C
BUENTING C
HEITMANN K
VLASSARA H
Citation: T. Koschinsky et al., ORALLY ABSORBED REACTIVE GLYCATION PRODUCTS (GLYCOTOXINS) - AN ENVIRONMENTAL RISK FACTOR IN DIABETIC NEPHROPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6474-6479
Citation: A. Bittner et al., EVALUATION OF MICRODIALYSIS AND FT-IR ATR-SPECTROSCOPY FOR IN-VIVO BLOOD-GLUCOSE MONITORING, Mikrochimica acta, 1997, pp. 827-828
Authors:
HE CJ
KOSCHINSKY T
SABOL J
BUENTING C
LIU C
VLASSARA H
Citation: Cj. He et al., MONONUCLEAR (MN) CELL AGE RECEPTOR-1 (AGE-R1) MESSENGER-RNA EXPRESSION AND ITS RELATIONSHIP TO DIABETIC COMPLICATIONS, Diabetes, 46, 1997, pp. 31-31
Authors:
KOSCHINSKY T
HE C
MITSUHASHI T
LIU C
BUENTING C
HEITMANN K
VLASSARA H
Citation: T. Koschinsky et al., IMPAIRED CLEARANCE OF TOXIC FOOD-DERIVED ADVANCED GLYCATION ENDPRODUCTS AS A RISK FOR DIABETIC NEPHROPATHY, Diabetologia, 39, 1996, pp. 257-257
Authors:
HASBACH J
KOSCHINSKY T
REINAUER H
GRIES FA
Citation: J. Hasbach et al., LOW-DOSE-ASPIRIN DOES NOT LOWER BLOOD-GLUCOSE IN NIDDM PATIENTS TREATED WITH GLIBENCLAMIDE, Diabetologia, 39, 1996, pp. 838-838
Authors:
KOSCHINSKY T
HE CJ
MITSUHASHI T
LIU C
BUENTING C
HEITMANN K
VLASSARA H
Citation: T. Koschinsky et al., REACTIVE ADVANCED GLYCATION ENDPRODUCTS (AGES) FROM FOOD - A NEW RISKFOR DIABETIC COMPLICATIONS, Diabetes, 45, 1996, pp. 464-464
Authors:
PALINSKI W
KOSCHINSKY T
BUTLER SW
MILLER E
VLASSARA H
CERAMI A
WITZTUM JL
Citation: W. Palinski et al., IMMUNOLOGICAL EVIDENCE FOR THE PRESENCE OF ADVANCED GLYCOSYLATION END-PRODUCTS IN ATHEROSCLEROTIC LESIONS OF EUGLYCEMIC RABBITS, Arteriosclerosis, thrombosis, and vascular biology, 15(5), 1995, pp. 571-582
Authors:
FISHBANE S
BUCALA R
KOSCHINSKY T
GIORDANO D
FOUNDS H
VLASSARA H
Citation: S. Fishbane et al., SIGNIFICANT REDUCTION OF PLASMA LDL-APO-B AND GLYCATED APO-B FOLLOWS CHRONIC HIGH-FLUX HEMODIALYSIS IN DIABETIC UREMIC PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 487-487
Authors:
BUCALA R
FISHBANE S
KOSCHINSKY T
GIORDANO D
SADEGHI H
FOUNDS H
CERAMI A
VLASSARA H
Citation: R. Bucala et al., HEMODIALYSIS REDUCES BOTH APO B MODIFICATION BY ADVANCED GLYCATION ENDPRODUCTS (AGES) AND TOTAL CIRCULATING APO-B IN DIABETIC-PATIENTS WITHEND-STAGE RENAL-DISEASE, Diabetologia, 38, 1995, pp. 162-162
Authors:
BUCALA R
MAKITA Z
VEGA G
GRUNDY S
KOSCHINSKY T
CERAMI A
VLASSARA H
Citation: R. Bucala et al., MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ADVANCED GLYCATION END-PRODUCTS CONTRIBUTES TO THE DYSLIPIDEMIA OF DIABETES AND RENAL-INSUFFICIENCY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(20), 1994, pp. 9441-9445
Citation: T. Koschinsky et al., GLUCOMETER ELITE - EVALUATION OF A NEW TEST SYSTEM FOR SELF-MONITORING OF BLOOD-GLUCOSE, Diabetes, 43, 1994, pp. 10000227-10000227
Citation: Hm. Heise et al., MULTICOMPONENT ASSAY FOR BLOOD SUBSTRATES IN HUMAN PLASMA BY MIDINFRARED SPECTROSCOPY AND ITS EVALUATION FOR CLINICAL ANALYSIS, Applied spectroscopy, 48(1), 1994, pp. 85-95
Authors:
BUCALA R
MAKITA Z
KOSCHINSKY T
CERAMI A
VLASSARA H
Citation: R. Bucala et al., LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 90(14), 1993, pp. 6434-6438
Authors:
SOBENIN IA
TERTOV VV
KOSCHINSKY T
BUNTING CE
SLAVINA ES
DEDOV II
OREKHOV AN
Citation: Ia. Sobenin et al., MODIFIED LOW-DENSITY-LIPOPROTEIN FROM DIABETIC-PATIENTS CAUSES CHOLESTEROL ACCUMULATION IN HUMAN INTIMAL AORTIC-CELLS, Atherosclerosis, 100(1), 1993, pp. 41-54
Authors:
KOSCHINSKY T
BUCALA R
MAKITA Z
BUNTING CE
FUH H
VLASSARA H
Citation: T. Koschinsky et al., ADVANCED GLYCOSYLATION OF LDL-APOPROTEIN-B AND LDL-APOPROTEIN-LIPIDS - ITS RELATIONSHIP TO DIABETIC LATE COMPLICATIONS, Diabetologia, 36, 1993, pp. 10000081-10000081